Expertise Term: drug development
 NameInstitutionRole
Bitan, GalUniversity of California Los AngelesEditorial Board Member
 
 
Name: Bitan, Gal
Role: Editorial Board Member
Email: gbitan@mednet.ucla.edu
Institution: University of California Los Angeles
Department: Brain Research Institute/Neurology Dept.
Subject Categories:
Expertise Terms: alpha-synuclein (a-synuclein), Alzheimer disease, amyloid, amyloid-beta (AB), drug development, exosome (vesicle), extracellular vesicles, molecular bases of disease, protein aggregation, protein misfolding
Clark, RichardThe University of QueenslandEditorial Board Member
 
 
Name: Clark, Richard
Role: Editorial Board Member
Email: richard.clark@uq.edu.au
Institution: The University of Queensland
Department: School of Biomedical Scuences
Subject Categories:
Expertise Terms: drug design, drug development, natural product, nicotinic acetylcholine receptors (nAChR), peptide chemical synthesis, peptide conformation, peptide hormone, peptide interaction, peptides, toxin
Kostenis, EviUniversity of BonnEditorial Board Member
 
 
Name: Kostenis, Evi
Role: Editorial Board Member
Email: kostenis@uni-bonn.de
Institution: University of Bonn
Department:
Subject Categories:
Expertise Terms: arrestin, bioluminescence, bioluminescence resonance energy transfer (BRET), biosensor, biotechnology, cell biology, cell signaling, cyclic AMP (cAMP), drug development, drug screening, fatty acid, G protein, G protein-coupled receptor (GPCR), inositol 1,4,5-trisphosphate (IP3), molecular bases of disease, molecular pharmacology, signal transduction, signaling
Liu, XuedongUniversity of Colorado BoulderEditorial Board Member
 
 
Name: Liu, Xuedong
Role: Editorial Board Member
Email: Xuedong.Liu@colorado.edu
Institution: University of Colorado Boulder
Department: Biochemistry
Subject Categories:
Expertise Terms: ADAMTS, cell migration, cell signaling, drug development, drug screening, mitochondria, mitophagy, parkin, PTEN-induced putative kinase 1 (PINK1), ubiquitin